All Stories

  1. Diabetes type 2: magnitudes of agonist-evoked platelet activity markers in vitro demonstrate a substantial individual dependence

    Article • Blood Coagulation & Fibrinolysis, May 2026, Wolters Kluwer Health

    Maria Edvardsson

  2. Type 2 Diabetes: Platelets and Long-Term Metabolic Control as Estimated from Glycosylated Haemoglobin (HbA1c)

    Article • Hämostaseologie, December 2025, Thieme Publishing Group

    Maria Edvardsson

  3. Precision Medicine: Personalizing Healthcare by Bridging Aging, Genetics, and Global Diversity

    Article • Healthcare, June 2025, MDPI AG

    Maria Edvardsson

  4. Type 2 Diabetes: Platelets and Long-Term Metabolic Control as Estimated from Glycosylated Haemoglobin (HbA1c)

    Article • Hämostaseologie, March 2024, Thieme Publishing Group

    Maria Edvardsson

  5. Diabetes type 2: relationships between lysosomal exocytosis of circulating normal-sized platelets and in vitro ɑ-thrombin-evoked platelet responses

    Article • Annals of Medicine, March 2023, Taylor & Francis

    Maria Edvardsson

  6. Small procoagulant platelets in diabetes type 2

    Article • Thrombosis Research, November 2020, Elsevier

    Maria Edvardsson

  7. Reduced survival time in frail elderly with elevated levels of CRP or IL-8.

    Article • Scandinavian Journal of Clinical and Laboratory Investigation, May 2019, Taylor & Francis

    Maria Edvardsson

  8. Differences in levels of albumin, ALT, AST, γ-GT and creatinine in frail, moderately healthy and healthy elderly individuals

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), October 2017, De Gruyter

    Maria Edvardsson

  9. Clinical use of conventional reference intervals in the frail elderly

    Article • Journal of Evaluation in Clinical Practice, December 2014, Wiley

    Maria Edvardsson